Category: Infectious Diseases
Could Science Be Synonymous With Courage? The News This Week Is Timely
As Fischer and Wohl Fight Disease in Sub-Saharan Africa, the U.S. Department of Health and Human Services’ Administration for Strategic Preparedness and Response (ASPR) Selects UNC to be a Regional Emerging Special Pathogen Treatment Center (RESPTC). See press announcement. Many courageous infectious disease specialists and other clinicians have not shied away from caring for tho … Read more
Dr. Boyce Receives Jefferson-Pilot Fellowship in Academic Medicine
Ross Boyce, MD, MSc, assistant professor in the Division of Infectious Diseases and Department of Epidemiology, has been selected as one of the recipients of the Jefferson-Pilot Fellowships in Academic Medicine. This award is given to exceptional UNC School of Medicine (SOM) junior faculty. “I am honored to receive this award,” said Dr. Boyce. “I know there are many talented and … Read more
Department of Medicine Grants & Funding: September 1 – September 30, 2022
Division of Gastroenterology and Hepatology Andrew Moon, MD has received a $200,000 (AASLD) Clinical, Translational and Outcomes Research Award (CTORA) from the American Association for the Study of Liver Diseases for his grant on “Incorporating the Patient Voice into Hepatocellular Carcinoma Treatment Models”. Division of Rheumatology, Allergy and Immunology Doug Phanstiel, PhD … Read more
The Leadership and Teamwork Behind 6 and 8 Bedtower
From managing the day-to-day operations, ensuring patients receive the highest level of care, budgeting and staffing, our nurse managers are like business owners of their unit. And it takes a team to run a successful business. Nikia Smith, BSN, RN, NE-BC, and Turkeisha Brown, MSN, RN, NE-BC, have both been nurse managers at the University of North Carolina for 12 years. Smith ove … Read more
IGHID Investigators Discuss Projects As New Academic Year Begins
Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious Diseases (IGHID) contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of global populations. Their multi-disciplinary findings will be u … Read more
Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis
Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, UNC School of Medicine researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin. Read more.
Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women – Findings from HPTN 084 Study
Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021). Read more.
Addressing Racism’s Role in the US HIV Epidemic: Qualitative Findings from Three “Ending the HIV Epidemic” Prevention Projects
Researchers from the Institute for Global Health and Infectious Diseases, the Gillings School of Global Public Health, and Center for Health Equity Research reviewed qualitative data from three “Ending the HIV Epidemic” (EHE) projects, published in the July issue of Journal of Acquired Immune Deficiency Syndrome (JAIDS). In the article, Kate Muessig, PhD, associate professor in t … Read more
Victoria Shelus Studies Antimalarial Drug Use and Practice at Drug Shops in Uganda
Victoria Shelus studies antimalarial drug use and practice at drug shops in Uganda, building on the work of Dr. Ross Boyce. In the remote villages of Bugoye sub-county at the foot of Uganda’s Rwenzori Mountains a rolling landscape stretches across lush river valleys and steep hillsides. It’s the kind of terrain that might make for a beautiful and strenuous weekend hike for visito … Read more
Juliano Receives $3.4 million to Study the Increase of Relapsing Malaria Species in Africa
Jonathan Juliano, MD, MPSH, Professor of Infectious Diseases and Associate Director of the Institute for Global Health and Infectious Diseases, with fellow IDEEL investigators Jessica Lin, MD, MSCR, and Jonathan Parr, MD, MPH, and co-PIs from the University of Florida (UF) and Centre Pasteur Cameroon, has received a $3.4 million R01 grant award to study the changing epidemiology … Read more
Department of Medicine Grants & Funding: August 1 – August 31, 2022
Division of Rheumatology, Allergy and Immunology Amanda Nelson, MD, MSCR, RhMSUS, received, a 5-Year, $3.4M NIH grant to investigate intestinal permeability in multi-joint osteoarthritis Saira Sheikh, MD, and team receive $500K NIH U01 “Innovation Award” from FDA’s Office of Minority Health & Health Equity, to advance diversity and representation in lupus. Amanda Nelson, MD, … Read more
Juliano Honored With IDSA Designation
Jonathan J. Juliano, MD, MSPH, has been named Fellow by the Infectious Diseases Society of America (IDSA), the nation’s leading infectious diseases professional society. Fellowship in IDSA is one of the highest honors in the field of infectious diseases. It recognizes distinguished physicians and scientists from the United States and around the world who have achieved professiona … Read more